ArticleRSC advances2025
Bleeding inhibiting, highly absorbent 3D-printed curdlan-based dressing insert for medical applications.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Essential Oils from Seed-Depleted Infructescences of Industrial Hemp: Chemical Diversity and Biological Potential.Molecules (Basel, Switzerland) · 2026Article
- Chemical Characteristics and Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exudative wounds pose a significant challenge in clinical practice, as excessive exudate can delay the healing process and increase the risk of infection. In response to the demand for advanced dressings that not only effectively absorb excess exudate but also actively support tissue regeneration, innovative biocompatible biomaterials have been developed using 3D printing technology. Thanks to the developed synthesis method, the curdlan-based materials were enriched with calcium ions and engineered to possess a porous structure, high hydrophilicity, and significant fluid absorption capacity. A notable advantage of the proposed dressing inserts is their compact dry form, which makes them easy to handle and integrate into multilayer wound dressing systems. Despite their small size, the materials can absorb substantial amounts of fluid, making them particularly promising for the treatment of highly exuding wounds, such as venous leg ulcers. Comprehensive analyses confirmed their thermal stability, biological safety (non-toxic, non-mutagenic, and hemocompatible), and the ability to stimulate skin cell proliferation. The obtained results highlight the strong potential of these biomaterials as next-generation dressing inserts for effective management of hard-to-heal wounds.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.